CSPC Jingfeng Hits Two Consecutive Daily Trading Limits as Innovative Drug Sector Gains Momentum

Source: Cailian Press

【Innovative Drug Concepts Repeatedly ActiveCSPC Jingfeng[2 Consecutive Limit-Ups] Cailianshe, July 3: The innovative drug concept has repeatedly shown strong activity, with CSPC Jingfeng hitting two consecutive limit-ups.Chengdu Easton Bio Pharmaceuticals Co.,LtdUp over 12%,InventisBio、Hotgen、BeOne、Aidea PharmaceuticalFollowing the Rally. On the news front, the 12th National Centralized Drug Procurement explicitly includes only mature generic drugs, excluding innovative drugs within their patent period. The industry’s policy orientation has comprehensively shifted from cost containment and price reduction to fostering excellence and strengthening competitiveness.